On Inference When Using State Corporate Laws for Identification
Posted by Holger Spamann (Harvard Law School), on Thursday, December 19, 2019 Editor's Note: Holger Spamann is Professor of Law at Harvard Law School. This post is based on his recent paper. Related...
View ArticleManagerial Control Benefits and Takeover Market Efficiency
Posted by Wenyu Wang (Indiana University) and Yufeng Wu (University of Illinois), on Saturday, December 28, 2019 Editor's Note: Wenyu Wang is Associate Professor of Finance at Indiana University Kelley...
View ArticleDo Staggered Boards Affect Firm Value?
Posted by Steven Davidoff Solomon, UC Berkeley School of Law, on Thursday, April 20, 2017 Editor's Note: Steven Davidoff Solomon is a Professor of Law at UC Berkeley School of Law. This post is based...
View ArticleLearnings from Some Recent Contested Cases Before the UK Takeover Panel
Posted by Selina Sagayam, Gibson, Dunn & Crutcher LLP, on Saturday, July 22, 2017 Editor's Note: Selina S. Sagayam is the Head of UK Transactional Practice Development in the London office of...
View ArticleBy the Numbers: Venture-Backed IPOs in 2016
Posted by Richard C. Blake and Heidi E. Mayon, Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, on Wednesday, July 26, 2017 Editor's Note: Richard C. Blake and Heidi E. Mayon are...
View ArticleWhich Antitakover Provisions Matter?
Posted by Jonathan M. Karpoff (University of Washington), Robert J. Schonlau (Brigham Young University), and Eric W. Wehrly (Western Washington University), on Saturday, April 28, 2018 Editor's Note:...
View ArticleNon-Delaware Decisions on Director Nominations
Posted by David Berger, Amy Simmerman and Adrian S. Broderick, Wilson Sonsini Goodrich & Rosati, on Monday, May 21, 2018 Editor's Note: David Berger and Amy Simmerman are partners and Adrian S....
View ArticleUnderstanding the Dutch Poison Pill
Posted by Seve Jan van der Graaf, Glass, Lewis & Co., on Tuesday, June 19, 2018 Editor's Note: Seve Jan van der Graaf is an analyst at Glass, Lewis & Co. This post is based on a Glass Lewis...
View ArticleTrade Secrets Protection and Antitakeover Provisions
Posted by Aiyesha Dey (Harvard Business School) and Joshua T. White (Vanderbilt University), on Wednesday, June 27, 2018 Editor's Note: Aiyesha Dey is Høegh Family Associate Professor of Business of...
View ArticleDoes Protectionist Anti-Takeover Legislation Lead to Managerial Entrenchment?
Posted by Marc Frattaroli (EPFL), on Wednesday, March 27, 2019 Editor's Note: Marc Frattaroli is a PhD candidate at the Swiss Finance Institute at Ecole Polytechnique Fédérale de Lausanne (EPFL). This...
View Article2019 Proxy Voting and Engagement Guidelines: North America
Posted by Rick Lacaille and Rakhi Kumar, State Street Global Advisors, on Wednesday, March 27, 2019 Editor's Note: Rick Lacaille is Executive Vice President and Global Chief Investment Officer and...
View ArticleViolation of DGCL Section 203 and Stockholder Enforcement Rights
Posted by Andrew G. Gordon, Jaren Janghorbani, and Ross A. Fieldston, Paul, Weiss, Rifkind, Wharton & Garrison LLP, on Monday, July 22, 2019 Editor's Note: Andrew G. Gordon, Jaren Janghorbani, and...
View ArticleThe Consequences to Directors of Deploying Poison Pills
Posted by William C. Johnson (Suffolk University), Jonathan M. Karpoff (University of Washington), and Michael D. Wittry (Ohio State University), on Monday, October 21, 2019 Editor's Note: William C....
View ArticleFiduciary Duties During a Time of Volatility
Posted by Ethan Klingsberg and Vinita Sithapathy, Freshfields Bruckhaus Deringer LLP, on Tuesday, April 7, 2020 Editor's Note: Ethan Klingsberg is a partner and Vinita Sithapathy is an associate at...
View ArticleThe Return of Poison Pills: A First Look at “Crisis Pills”
Posted by Ofer Eldar (Duke University) and Michael Wittry (Ohio State University), on Wednesday, May 6, 2020 Editor's Note: Ofer Eldar is an Associate Professor of Law and Finance at the Duke...
View ArticleComment Letter on Control Shares Statutes and Registered Investment Companies
Posted by Phillip Goldstein, Bulldog Investors, on Saturday, August 8, 2020 Editor's Note: Phillip Goldstein is the co-founder of Bulldog Investors. This post is based on his letter to the SEC Division...
View ArticleThe Withdrawal of the Boulder Letter
Posted by Phillip Goldstein, Bulldog Investors, on Tuesday, September 29, 2020 Editor's Note: Phillip Goldstein is the co-founder of Bulldog Investors. This post is based on his comment letter to the...
View ArticleDelaware Court Enjoins Poison Pill Adopted in Response to Market Disruption
Posted by Mark McDonald, James Langston, and Kyle Harris, Cleary Gottlieb Steen & Hamilton LLP, on Saturday, March 20, 2021 Editor's Note: Mark McDonald, James Langston, and Kyle Harris are...
View ArticlePoison Pills After Williams: Not Only for When Lightning Strikes
Posted by Ethan Klingsberg, Paul Tiger, and Elizabeth Bieber, Freshfields Bruckhaus Deringer LLP, on Sunday, March 21, 2021 Editor's Note: Ethan Klingsberg and Paul Tiger are partners and Elizabeth K....
View ArticleThe Structure of the Board of Directors: Boards and Governance Strategies in...
Posted by Klaus J. Hopt (Max Planck Institute) and Patrick C. Leyens (University of Bremen), on Monday, April 12, 2021 Editor's Note: Klaus J. Hopt is former director at the Max Planck Institute for...
View Article
